Sharon Bio-Medicine Financials

NSE: SHARONBIO | BSE: 532908

₹3.30

₹-0.15 (-4.35%)

As on 28-Mar-2019IST

Market cap

₹2 Cr

Revenue (TTM)

₹240 Cr

P/E Ratio

0.1

P/B Ratio

-0.1

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Operating Revenue	240.45	197.48	190.23	192.22	188.39	138.81
Total Income	251.96	205.25	254.20	196.67	191.20	158.66
Total Expenditure	181.22	153.87	162.80	168.20	162.19	444.48
EBITDA	59.23	43.61	27.43	24.01	26.20	-305.68
Depreciation	7.85	8.77	9.70	9.40	11.23	16.12
EBIT	51.38	34.84	17.73	14.61	14.97	-321.80
Interest	8.93	11.58	10.34	0.06	0.11	29.87
Other Income	11.50	7.76	63.98	4.46	2.81	19.85
Exceptional Items	--	--	--	--	--	-13.70
Profit before Tax	53.95	31.03	71.37	19.01	17.67	-345.52
Provision for Tax	12.94	7.85	-19.03	--	--	2.34
Profit after Tax	41.01	23.18	90.40	19.01	17.67	-347.86

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Shareholder's Funds	90.38	48.83	25.14	-614.69	-609.22	-555.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	39.03	117.54	127.95	564.31	565.43	519.86
Current Liabilities	85.14	35.85	31.55	341.36	342.93	389.31
Total Liabilities	214.55	213.23	203.67	290.98	299.14	353.60

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Non-Current Assets	110.04	112.10	113.21	115.63	143.82	298.74
Current Assets	104.52	87.26	71.43	175.34	155.32	54.86
Total Assets	214.55	213.23	203.67	290.98	299.14	353.60
Total Debt*	86.39	122.93	140.67	827.32	827.32	727.19
Net Current Assets	19.38	51.41	39.88	-166.01	-187.61	-334.46
Contingent Liabilities	1.67	5.33	8.15	144.45	143.54	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Cash From Operating Activities	45.06	38.17	66.92	41.11	22.96	33.92
Cash Flow from Investing Activities	1.05	-8.99	-8.09	-2.77	-3.24	-1.38
Cash from Financing Activities	-45.18	-29.36	-148.53	0.02	0.03	-36.93
Net Cash Inflow / Outflow	0.93	-0.17	-89.70	38.36	19.74	-4.39

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Adjusted EPS (₹)	16,404.80	9,271.60	36,159.20	33.02	30.71	-29.25
Cash EPS (₹)	--	--	--	49.36	50.22	-27.89
Adjusted Book Value (₹)	36,153.20	19,532.40	10,056.40	-1,068.10	-1,130.02	-46.71
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	--	--	71.44	39.89	2.85
Free Cash Flow per Share (₹)	8,181.20	3,742.80	--	64.72	32.24	-12.07

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
ROCE (%)	36.08	25.24	43.18	9.79	4.32	-77.23
ROE (%)	58.92	62.67	--	--	--	--
ROA (%)	19.68	11.98	38.01	6.44	3.46	-64.63
EBIT Margin (%)	21.37	17.64	9.32	7.60	7.95	-231.83
Net Margin (%)	16.28	11.29	35.56	9.66	9.24	-219.25
Cash Profit Margin (%)	20.32	16.18	52.62	14.78	15.34	-236.42

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Revenue Growth (%)	21.76	3.82	-1.04	2.03	-25.67	-45.23
EBIT Growth (%)	47.45	96.54	21.34	-2.42	--	-116.18
Net Profit Growth (%)	76.94	-74.36	375.65	7.53	105.91	-16.26
EPS Growth (%)	76.94	-74.36	--	7.54	205.00	-16.26
Book Value Growth (%)	85.09	94.23	104.09	5.49	-218.43	-172.01

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	-0.17
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.21	2.39	1.54	25.94	26.77	-2.86
Close Price (₹)	--	--	--	--	--	8.05
High Price (₹)	--	--	--	--	--	14.40
Low Price (₹)	--	--	--	--	--	7.60
Market Cap (₹ Cr)	--	--	--	--	--	96.10

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Debt to Equity	0.96	2.52	5.60	-1.35	-1.27	-1.31
Short term debt to equity ratio	0.25	--	--	-0.44	-0.44	-0.41
Current Ratio	1.23	2.43	2.26	0.51	0.45	0.14
Quick Ratio	0.74	1.45	1.46	0.40	0.33	0.09
Interest Coverage	7.04	3.68	7.90	307.53	161.10	-10.57

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-17	Mar-16	Jun-15	Jun-14	Jun-13	Jun-12
Debtors to sales (%)	21.27	20.31	14.69	13.57	14.27	15.58
Asset Turnover	1.15	1.02	0.80	0.65	0.37	0.26
Receivable days	69.26	62.90	51.84	50.29	203.48	266.37
Inventory Days	58.25	56.24	61.83	77.23	215.36	261.45
Payable days	85.50	95.46	155.83	172.58	180.45	63.30
Cash Conversion Cycle	42.01	23.69	-42.16	-45.06	238.40	464.51